Delivery Order SPE2DB20D3101-SPE2DB22FK3B5
- Not listed
- This federal contract award, valued at $3,650.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Cyclosporine 0.05% Eye Emulsion, with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,108.58 firm fixed price delivery order is for the procurement of Cyclosporine 0.05% eye emulsion, with a completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,870.90 Firm Fixed Price Delivery Order is for the supply of Cyclosporine 0.05% Eye Emulsion, a specialized ophthalmic medication. The contract has an ultimate completion date of October 26, 2023 and was awarded on October 25, 2023. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,556.38 Firm Fixed Price delivery order is for the procurement of Cyclosporine 0.05% Eye Emulsion, a prescription eye medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,279.87, is a delivery order for the supply of cyclosporine 0.05% eye emulsion. The contract has an ultimate completion date of May 30, 2023 and is a firm fixed-price, non-set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.16 firm fixed price delivery order is for the supply of 4565747846 ! CYCLOSPORINE 0.05% EYE EMULSION 30S. The contract has a period of performance through September 11, 2024 and was awarded on September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,144.44 Firm Fixed Price Delivery Order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product. The award has a period of performance through February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The Firm Fixed Price delivery order, valued at $12,674.13, was awarded on August 19, 2024 with a completion date of August 20, 2024. This contract is not designated as a set-aside. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts to provide a diverse...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, with a ceiling value of $1,088.96 and a period of performance through February 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical and medical supply distributor. The contract is a Delivery Order valued at $3,021.49 for the delivery of cyclosporine 0.05% eye emulsion, with an ultimate completion date of April 24, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK3B5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,784.10 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty medication. The contract has a completion date of July 5, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award has no set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/1/22 |